Effects recombinant human tumor necrosis factor rodent gliomas normal brain study possible therapeutic effects recombinant human tumor necrosis factor-alpha rHuTNF-alpha malignant gliomas expression tumor necrosis factor TNF -receptors glioma cells vitro rat experimental glioma model growth inhibition effect vitro concentration micrograms/ml rHuTNF-alpha Receptor-binding studies cells present specific receptors rHuTNF-alpha pharmacokinetics rHuTNF-alpha intravenous injection respect tissue brain tumor concentrations glioma concentrations mean standard error mean ng TNF/mg brain ng TNF/mg brain normal contralateral No therapeutic effect solid gliomas stereotactic injection micrograms microliter buffer solution tumor animals Immunohistochemical studies stereotactic injection rHuTNF-alpha total disappearance substance hours internalization tumor cells Stereotactic injection micrograms microliters normal brain marked inflammatory response injection track microvascular thrombosis results rHuTNF direct indirect cytotoxic activity glioma cells Furthermore clinical use rHuTNF-alpha malignant gliomas authors receptor studies patient receptor-positive patients treatment rHuTNF-alpha precautions local encephalitic reactions 